Getting insurance to pay for a breast MRI typically comes down to proving medical necessity, which means showing you meet specific risk criteria that insurers use as their coverage threshold. The most widely recognized cutoff is a 20% or greater lifetime risk of developing breast cancer, calculated using a standardized risk assessment tool. If you meet that bar, or fall into certain other qualifying categories, your chances of full coverage are strong. If you don’t, you still have options depending on your state, your diagnosis, and how your doctor codes the order.
Who Qualifies Automatically
Insurance companies follow clinical guidelines from organizations like the American College of Radiology when deciding what counts as medically necessary. The clearest path to coverage is falling into one of these categories:
- Known genetic mutations. Carriers of BRCA1, BRCA2, TP53, or PTEN gene mutations qualify. So do people with a first-degree relative (parent, sibling, child) who carries one of these mutations, even if you haven’t been tested yourself.
- Lifetime risk of 20% or higher. This is calculated using models like the Tyrer-Cuzick tool, which factors in family history, breast density, prior biopsies, and other variables. Your doctor or a breast center can run this calculation.
- Chest radiation between ages 10 and 30. If you received radiation to the chest area during those years, typically for conditions like Hodgkin lymphoma, you qualify for annual MRI screening starting around age 25.
- Personal history of breast cancer with dense breasts. The ACR recommends annual supplemental MRI for women diagnosed before age 50 or those with a personal history of breast cancer combined with dense breast tissue.
- Atypical cells found on biopsy. If a previous biopsy showed atypical ductal hyperplasia, atypical lobular hyperplasia, or lobular carcinoma in situ, MRI screening is strongly recommended, especially when other risk factors are present.
If you fit any of these profiles, coverage is straightforward in most cases. The key step is making sure your doctor documents the qualifying condition clearly in the order.
Get Your Risk Score Before the Appointment
If you don’t have a known genetic mutation or prior cancer diagnosis, your lifetime risk score is the single most important number for getting coverage. Aetna, for example, explicitly requires a 20 to 25% or greater lifetime risk calculated by an approved model like Tyrer-Cuzick, BRCAPRO, or the Claus model. Other major insurers follow similar thresholds.
You can ask your doctor or a breast imaging center to run a Tyrer-Cuzick assessment before ordering the MRI. This model accounts for more variables than basic tools, including breast density and detailed family history on both sides, so it often produces a higher (and more accurate) risk estimate. If your score comes back at or above 20%, that number should be included in the MRI order and any prior authorization paperwork. Without it documented, insurers may deny the claim even if you clearly qualify.
How Prior Authorization Works
Most insurers require prior authorization for breast MRI, meaning your doctor’s office submits a request with supporting clinical information before the scan is scheduled. The insurer reviews it against their coverage policy and either approves, denies, or requests more documentation.
Based on major insurer policies like Aetna’s, the clinical data points they look for include your lifetime risk calculation with the specific model named, genetic testing results or family mutation status, pathology reports from any prior biopsies, history of chest radiation with dates, and breast density classification from your most recent mammogram. The more of this information your doctor includes upfront, the less likely you are to face a denial or a request for additional records that delays scheduling by weeks.
If your doctor’s office handles a lot of breast imaging referrals, they likely know what your specific insurer requires. It’s worth asking them directly: “What documentation are you including with the prior auth?” If anything relevant is missing, such as a risk score or a pathology report from years ago at a different facility, flag it before the request goes in.
Dense Breasts: Check Your State Laws
If you have dense breast tissue, which affects roughly half of women getting mammograms, you may have coverage through a state law even if your lifetime risk score falls below 20%. More than 30 states have passed laws requiring insurers to cover supplemental screening for dense breasts, and many of these laws prohibit cost-sharing entirely.
States with these laws already in effect include Connecticut, Louisiana, Tennessee, Washington, Texas, Georgia, Montana, and many others. Several more states have laws taking effect in 2025 and 2026, including New York, Illinois, Massachusetts, Virginia, Colorado, and Idaho. In most of these states, coverage applies to one supplemental screening per year, which can be an MRI or ultrasound, with no copay, coinsurance, or deductible applied.
There is an important limitation: these state laws generally apply only to state-regulated insurance plans. If your employer self-funds its health plan (common at large companies), the plan is regulated under federal law and may not be bound by your state’s mandate. You can find out by checking your plan documents or calling the number on your insurance card and asking whether your plan is “fully insured” or “self-funded.”
Screening vs. Diagnostic Coding Matters
How your breast MRI is coded on the insurance claim affects what you pay. Under the Affordable Care Act, preventive screenings like mammograms must be covered with no cost-sharing. But that federal protection does not currently extend to breast MRI, even when it’s used for screening purposes. This means a screening breast MRI can still come with a copay, coinsurance, or deductible in states without supplemental screening laws.
A diagnostic MRI, ordered to investigate a specific finding like a suspicious area on a mammogram or a BI-RADS 3 lesion being monitored, is subject to your plan’s normal cost-sharing for diagnostic imaging. The current billing codes for breast MRI (CPT 77046, 77047, 77048, and 77049) don’t distinguish between screening and diagnostic purposes, which sometimes creates confusion in how claims are processed.
The practical takeaway: ask your doctor whether the MRI is being ordered as screening or diagnostic, and confirm with your insurer how your plan handles each. If you’re on a high-deductible plan, the difference is significant. Research published in the Journal of the National Cancer Institute found that women on high-deductible plans paid an average of $549 out of pocket for screening breast MRI, compared to $251 for women on other plan types.
What to Do If Your Claim Is Denied
A denial is not the final answer. You have the right to appeal, and insurers are required by federal law to provide a process for both internal and external review.
Start by reading the denial letter carefully. It will state the specific reason for denial, whether that’s “not medically necessary,” “incomplete documentation,” or a policy exclusion. Each reason calls for a different response:
- Not medically necessary. Ask your doctor to submit a letter of medical necessity explaining why MRI is appropriate for your specific situation. This letter should reference your risk score, genetic status, breast density, family history, or prior findings. Include copies of supporting documents like pathology reports, genetic test results, or your Tyrer-Cuzick assessment.
- Incomplete documentation. This is often the easiest to fix. Gather the missing records and resubmit. Common gaps include a risk calculation that wasn’t included or a prior biopsy result that’s in a different health system’s records.
- Policy exclusion. If your insurer says breast MRI isn’t covered under any circumstances for your situation, check whether your state has a dense breast screening law that overrides this. If your plan is self-funded and state law doesn’t apply, an external appeal to an independent reviewer is your next step.
Keep copies of everything: denial letters, appeal submissions, medical records you send, and dates of phone calls. The National Association of Insurance Commissioners recommends maintaining a detailed paper trail throughout the process. If your internal appeal is denied, you can request an external review, where an independent third party evaluates your case. This external review is binding on the insurer in most situations.
If Coverage Isn’t an Option
When insurance won’t cover a breast MRI and appeals are exhausted, an abbreviated breast MRI (sometimes called “fast MRI”) is a lower-cost alternative offered by some imaging centers. It’s a shorter version of the full exam that still uses contrast and captures the most diagnostically important images. Duke University’s breast imaging program, for example, offers an abbreviated protocol for $400 out of pocket, which is substantially less than the $1,000 to $3,000 a full breast MRI can cost without insurance.
Not every imaging center offers this option, but it’s becoming more widely available. Call breast imaging centers in your area and ask specifically about abbreviated or fast breast MRI protocols and their self-pay pricing. Some centers also offer payment plans or financial assistance programs that can bring costs down further.